The agency’s has weighed in on 536 new claims.
For three months, industry has awaited the European Food Safety Authority’s (EFSA) fifth batch of general function health claims. Now, the agency’s expert NDA Panel has weighed in on 536 new claims.
Here’s the NDA Panel’s opinion of its approved claims:
The majority of submitted ingredient claims, were unsuccessful including:
With the support of EFSA’s reviews, the European Commission and its member states can now decide on whether or not to authorize claims on products relating to these ingredients.
EFSA will publish reviews of 35 remaining claims in July.
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.